Skip to content

Epidural Analgesia and Maternal Fever During Labor

Association Between the Effect of Epidural Analgesia and the Development of Maternal Fever During Labor: a Multicenter, Prospective, Observational, Cohort Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04940091
Enrollment
1051
Registered
2021-06-25
Start date
2021-06-10
Completion date
2022-03-21
Last updated
2025-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Analgesic Effect, Epidural Analgesia, Fever

Keywords

Epidural labor analgesia, Analgesic effect, Maternal fever during labor

Brief summary

Women who receive epidural analgesia during labor are more likely to develop fever than those who do not. Maternal fever during labor can produce various harmful effects on both mothers and infants. The investigators speculate that the effect of epidural analgesia is associated with the development of maternal fever, i.e., better analgesia is associated with higher risk of maternal fever.

Detailed description

Epidural related maternal fever (ERMF) refers to the phenomenon of increased body temperature of parturient after receiving epidural analgesia during labor. Women who receive epidural labor analgesia are more likely to have fever than those who do not. In a systematic review, 20-33% of parturients receiving neuraxial analgesia developed fever during labor, compared with only 5-7% of those without neuraxial analgesia. Maternal fever can interfere with women's laboring process, decrease the sensitivity of the uterus and cervix to oxytocin, and lead to dystocia and increased surgical delivery rate. The investigators note that the rate of ERMF is lower in patients receiving lower density neuraxial blockade. The study is designed to test the hypothesis that the effect of epidural analgesia is associated with the development of maternal fever, i.e., better analgesia is associated with higher risk of maternal fever.

Interventions

DRUGEpidural analgesia

Epidural analgesia is performed with a mixture of local anesthetics (ropivacaine) and opioids (sufentanil).

Sponsors

Guangdong Women and Children Hospital
CollaboratorOTHER
Tangshan Maternal and Child Health Hospital
CollaboratorOTHER
Dongguan Maternal and Child Health Hospital
CollaboratorUNKNOWN
Beijing Haidian Maternal and Child Health Hospital
CollaboratorOTHER
Beijing Fuxing Hospital
CollaboratorUNKNOWN
The Fourth Hospital of Shijiazhuang
CollaboratorOTHER
Xiamen Maternity & Child Care Hospital
CollaboratorOTHER
Peking University First Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥18 years old; * Nulliparae with single term cephalic pregnancy; * Preparing to give vaginal delivery under epidural analgesia.

Exclusion criteria

* Basal body temperature ≥37.3°C; * Presence of serious pregnancy complications (such as severe preeclampsia, placenta accreta, HELLP \[Hemolysis, Elevated Liver enzymes, Low Platelet count\] syndrome, placenta previa, abruption of placenta, or hyperthyroidism); * History of hyperthyrodism, including hyperthyrodism in pregnancy; * Taking sedatives and/or analgesics within one week before planned delivery; * American Society of Anesthesiologists classification \>class III; * Contraindications to epidural puncture, including central nervous system diseases (such as poliomyelitis), spinal diseases (such as intraspinal mass, lumbar disc herniation, history of spinal trauma, etc.), abnormal blood coagulation, etc.; * Presence of infections, including obstetric infections, systemic infections (such as sepsis, bacteremia), or infections at the puncture site or adjacent sites; * Other conditions that are considered unsuitable for study participation; * Refused to participate in the study.

Design outcomes

Primary

MeasureTime frameDescription
Occurrence of maternal fever during labordelivery ( the end of childbirth.)Maternal fever is defined as temperature of ≥38℃ during any stage of labor.

Secondary

MeasureTime frameDescription
Postpartum pain intensityAt 1, 10 and 42 days after childbirthPain intensity is assessed with numeric rating scale (NRS; an 11-point scale where 0=no pain and 10=the worst pain).
Postpartum breastfeedingAt 1, 10 and 42 days after childbirthThe status of breastfeeding include breastfeeding, formula milk, or a mix of them.
Occurrence of mild maternal fever during labordelivery ( the end of childbirth.)Mild maternal fever is defined as temperature of \>37.5℃ during any stage of labor.
Duration of labordelivery ( the end of childbirth.)Duration of the first, second, and third stage of labor.
Postpartum hospital stayUp to 42 days after childbirth.Postpartum hospital stay
Postpartum persistent painAt 42 days after childbirthDefined as NRS pain score ≥1 that persisted since childbirth. For those with persistent pain, also ask if the following activities was affected, including walking, mood, sleep or concentration, as judged by parturients themselves.
Postpartum depression scoreAt 10 and 42 days postpartumPostpartum depression is assessed with the the Edinburgh Postnatal Depression Scale. This is a 10-item self-report questionnaire; each item is rated from 0 to 3 denoting the increasing severity of symptoms, resulting in a maximum score of 30. A score ≥10 is defined as the presence of depression.
Postpartum complicationsUp to 42 days postpartumInclude maternal and neonatal complications, indicate new onset medical events that are harmful and required therapeutic intervention.
Neonatal Apgar scoreAt 1 and 5 minutes after birth.Apgar score is assessed at 1 and 5 minutes after birth.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026